GSK plc
corporate_fare Company Profile
GSK plc (NYSE:GSK) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 65 items for GSK at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- GSK's Jideytro Wins FDA Approval for ROS1-Positive Lung Cancer, First in Class from Nuvalent Deal
- EMA Accepts GSK's Filing for a Single-Dose Bexsero Booster in Adolescents and Adults
- GSK Ends Camlipixant Program for Chronic Cough After Split Phase III Outcome
- Jemperli Meets Phase II Rectal Cancer Goal, Putting GSK on Path to Accelerated US Review
- GSK's Licensor Delivers First-Ever Positive Phase III Survival Data for B7-H3 ADC Ris-Rez in Lung Cancer
Financial Snapshot
Insider Transactions
GSK files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.